Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 9.59% | 5.72% | -14.80% | -4.81% | 33.09% |
| Gross Profit | -9.59% | -5.72% | 14.80% | 1.13% | -54.08% |
| SG&A Expenses | 97.98% | -10.86% | -15.61% | -46.20% | -71.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3,383.33% | -- | -- | -- | -- |
| Total Operating Expenses | 27.54% | -2.25% | -15.17% | -24.85% | -27.05% |
| Operating Income | -27.54% | 2.25% | 15.17% | 23.38% | 22.55% |
| Income Before Tax | -31.51% | -16.52% | 96.74% | 21.16% | 21.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.51% | -16.52% | 96.74% | 21.16% | 21.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.51% | -16.52% | 96.74% | -93.43% | 40.08% |
| EBIT | -27.54% | 2.25% | 15.17% | 23.38% | 22.55% |
| EBITDA | -30.55% | 1.99% | 15.77% | 22.83% | 25.23% |
| EPS Basic | 76.95% | 46.81% | 67.94% | -87.94% | 41.97% |
| Normalized Basic EPS | 77.28% | 46.93% | 93.57% | 3.65% | 23.53% |
| EPS Diluted | 76.95% | 46.81% | 67.94% | -87.94% | 41.97% |
| Normalized Diluted EPS | 77.28% | 46.93% | 93.57% | 3.65% | 23.53% |
| Average Basic Shares Outstanding | 470.46% | 119.07% | 4.37% | 2.92% | 3.26% |
| Average Diluted Shares Outstanding | 470.46% | 119.07% | 4.37% | 2.92% | 3.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |